(Q37906977)

25 August 2017

1 reference

title

Sex steroid hormones and reproductive disorders: impact on women's health (English)

1 reference

25 August 2017

Vincenzo De Leo

16

0 references

Paolo Vercellini

object named as

Paolo Vercellini

12

0 references

Felice Petraglia

object named as

Felice Petraglia

17

0 references

Lone Hummelshoj

13

object named as

Lone Hummelshoj

1 reference

25 August 2017

9

Paul Devroey

1 reference

25 August 2017

11

Thomas D'Hooghe

1 reference

25 August 2017

6

Robert N Taylor

1 reference

25 August 2017

1

Bart C J M Fauser

1 reference

25 August 2017

Joop S E Laven

2

1 reference

25 August 2017

Basil C Tarlatzis

3

1 reference

25 August 2017

Kelle H Moley

4

1 reference

25 August 2017

Hilary O D Critchley

5

1 reference

25 August 2017

Sarah L Berga

7

1 reference

25 August 2017

Paul G Mermelstein

8

1 reference

25 August 2017

Luca Gianaroli

10

1 reference

25 August 2017

Susan Rubin

14

1 reference

25 August 2017

Angelique J Goverde

15

1 reference

25 August 2017

1 August 2011

1 reference

25 August 2017

Reproductive Sciences

1 reference

25 August 2017

18

1 reference

25 August 2017

8

1 reference

25 August 2017

702-712

1 reference

Metabolic impact of estrogen signalling through ERalpha and ERbeta

25 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Primary ovarian insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Clinical practice. Primary ovarian insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

IMS updated recommendations on postmenopausal hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Developmental origin of polycystic ovary syndrome - a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Genetics of ovarian disorders: polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Loci at chromosomes 13, 19 and 20 influence age at natural menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Consensus on infertility treatment related to polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Maternal diabetes causes mitochondrial dysfunction and meiotic defects in murine oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Endometrium in PCOS: Implantation and predisposition to endocrine CA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Pregnancy complications in PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Decreased oocyte-granulosa cell gap junction communication and connexin expression in a type 1 diabetic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Disordered meiotic regulation of oocytes by duration of diabetes mellitus in BBdp rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Polycystic ovary syndrome and pregnancy outcome: red herring or red flag?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Polycystic ovary syndrome, obesity and reproductive implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Obesity, pregnancy, inflammation, and vascular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Vascular dysfunction and metabolic parameters in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Oestrogen and progesterone regulation of inflammatory processes in the human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Spatiotemporal coupling of focal extracellular matrix degradation and reconstruction in the menstrual human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

VEGF blockade inhibits angiogenesis and reepithelialization of endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Endometriosis: cost estimates and methodological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Quantitative expression of apoptosis-regulating genes in endometrium from women with and without endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

A botanical extract from channel flow inhibits cell proliferation, induces apoptosis, and suppresses CCL5 in human endometriotic stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Emerging role of genomics in endometriosis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Nervous system physiology regulated by membrane estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Non-genomic actions of androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Rapid actions of androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

S-palmitoylation modulates estrogen receptor alpha localization and functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Plasma membrane estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Cognitive impairment associated with adjuvant therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111405068

21 January 2018

Identifiers

DOI

10.1177/1933719111405068

1 reference

25 August 2017

1 reference